Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07126353Not Yet Recruiting

Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

Role: collaborator

NCT06921993Not ApplicableNot Yet Recruiting

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Role: collaborator

NCT01593488Phase 2Unknown

Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children

Role: collaborator

All 3 trials loaded